Janke, C.* ; Rubio-Acero, R.* ; Weigert, M.* ; Reinkemeyer, C.* ; Khazaei, Y.* ; Kleinlein, L.* ; Le Gleut, R. ; Radon, K.* ; Hannes, M. ; Picasso, F.* ; Lucke, A.E.* ; Plank, M.* ; Kotta, I.C.* ; Paunovic, I.* ; Zhelyazkova, A.* ; Noreña, I.* ; Winter, S.* ; Hoelscher, M. ; Wieser, A.* ; Küchenhoff, H.* ; Castelletti, N.
Understanding the omicron variant impact in healthcare workers: Insights from the prospective COVID-19 post-immunization serological cohort in Munich (KoCo-Impf) on risk factors for breakthrough and reinfections.
Viruses 16:1556 (2024)
This study analyzes immune responses to SARS-CoV-2 vaccination and infection, including asymptomatic cases, focusing on infection risks during the Omicron wave, particularly among high-risk healthcare workers. In the KoCo-Impf study, we monitored 6088 vaccinated participants in Munich aged 18 and above. From 13 May to 31 July 2022, 2351 participants were follow-uped. Logistic regression models evaluated primary, secondary, and breakthrough infections (BTIs). Roche Elecsys® Anti-SARS-CoV-2 assays detected prior infections (via anti-Nucleocapsid antibodies) and assessed vaccination/infection impact (via anti-Spike antibodies) using dried blood spots. Our findings revealed an anti-Nucleocapsid seroprevalence of 44.1%. BTIs occurred in 38.8% of participants, with reinfections in 48.0%. Follow-up participation was inversely associated with current smoking and non-vaccination, while significantly increasing with age and receipt of three vaccine doses. Larger household sizes and younger age increased infection risks, whereas multiple vaccinations and older age reduced them. Household size and specific institutional subgroups were risk factors for BTIs. The anti-Nucleocapsid value prior to the second infection was significantly associated with reinfection risk. Institutional subgroups influenced all models, underscoring the importance of tailored outbreak responses. The KoCo-Impf study underscores the importance of vaccination, demographic factors, and institutional settings in understanding SARS-CoV-2 infection risks during the Omicron wave.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Covid-19 ; Orchestra ; Sars-cov-2 ; Antibodies ; Breakthrough Infections ; Health Care Workers ; Immunologic Response ; Reinfections ; Seroprevalence ; Vaccination; Sars-cov-2 Reinfection; Protection
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
1999-4915
e-ISSN
1999-4915
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 16,
Heft: 10,
Seiten: ,
Artikelnummer: 1556
Supplement: ,
Reihe
Verlag
MDPI
Verlagsort
St Alban-anlage 66, Ch-4052 Basel, Switzerland
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
30205 - Bioengineering and Digital Health
30505 - New Technologies for Biomedical Discoveries
Forschungsfeld(er)
Radiation Sciences
Enabling and Novel Technologies
PSP-Element(e)
G-501391-001
G-503800-001
G-540001-003
A-632200-001
Förderungen
German Federal Ministry of Education and Research (BMBF)
European Union
European Union's Horizon 2020 research and innovation program
Copyright
Erfassungsdatum
2024-10-31